Skip to main content

Table 3 Association between the presence or the absence of Metabolic syndrome and Hyperhomocysteinemia and LVH

From: Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese

 

Unadjusted

Model 1

Model 2

Model 3

LVMI

OR

95%CI

OR

95%CI

OR

95%CI

OR

95%CI

Non-MetS & normal Hcy

ref

 

ref

 

ref

 

ref

 

HHcy & Non-MetS

1.208*

1.049–1.391

1.201#

1.025–1.407

1.201#

1.025–1.407

1.175#

1.002–1.377

Normal Hcy & MetS

2.300*

2.006–2.638

1.820*

1.575–2.103

1.817*

1.572–2.100

1.615*

1.393–1.873

MetS & HHcy

2.284*

1.957–2.666

1.929*

1.627–2.286

1.921*

1.620–2.278

1.628*

1.364–1.944

LVMH2.7

OR

95%CI

OR

95%CI

OR

95%CI

OR

95%CI

Non-MetS & normal Hcy

ref

 

ref

 

ref

   

HHcy & Non-MetS

1.760*

1.494–2.074

1.291#

1.082–1.541

1.291#

1.081–1.541

1.248#

1.044–1.492

Normal Hcy & MetS

3.261*

2.787–3.815

2.974*

2.528–3.499

2.951*

2.508–3.473

2.567*

2.174–3.032

MetS & HHcy

4.143*

3.492–4.915

3.013*

2.519–3.603

2.960*

1.084–3.542

2.433*

2.019–2.932

  1. Model1 adjusted for gender, age, current smoking, current drinking, activity, education
  2. Model2 adjusted for gender, age, current smoking, current drinking, activity, education, high LDL-C
  3. Model3 adjusted for gender, age, current smoking, current drinking, activity, education, high LDL-C, hyperuricemia and medication treatment of hypertension or dyslipidemia
  4. * means P < 0.001,# means P < 0.05
  5. Abbreviations: LVH left ventricular hypertrophy, MetS metabolic syndrome